• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Eris Lifesciences Limited — Board Meeting, 24-11-2025: Outcome of Board Meeting

    24-11-2025 | 06:06 pm

    Eris Lifesciences board approved acquiring the remaining 30% of its subsidiary, Swiss Parenterals, for ₹423.30 Cr, making it a wholly-owned entity. The acquisition will be funded by issuing 23.06 lakh new shares. Shareholders' approval will be sought via postal ballot.

    No comments yet. Be the first to comment!

    All announcements from Eris Lifesciences Limited